Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Environ Toxicol ; 32(2): 594-608, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26991130

RESUMO

The aim of this study was to determine whether repeated exposure to iron oxide nanoparticles (Fe2 O3 -NPs) could be toxic to mice testis. Fe2 O3 -NPs (25 and 50 mg/kg) were intraperitoneally administered into mice once a week for 4 weeks. Our study showed that Fe2 O3 -NPs have the ability to cross the blood-testis barrier to get into the testis. The findings showed that exposure resulted in the accumulation of Fe2 O3 -NPs which was evidenced from the iron content and accumulation in the testis. Furthermore, 25 and 50 mg/kg Fe2 O3 -NPs administration increased the reactive oxygen species, lipid peroxidation, protein carbonyl content, glutathione peroxidase activity, and nitric oxide levels with a concomitant decrease in the levels of antioxidants-superoxide dismutase, catalase, glutathione, and vitamin C. Increased expression of Bax, cleaved-caspase-3, and cleaved-PARP confirms apoptosis. Serum testosterone levels increased with increased concentration of Fe2 O3 -NPs exposure. In addition, the histopathological lesions like vacuolization, detachment, and sloughing of germ cells were also observed in response to Fe2 O3 -NPs treatment. The data from our study entailed that testicular toxicity caused by Fe2 O3 -NPs exposure may be associated with Fe2 O3 -NPs accumulation leading to oxidative stress and apoptosis. Therefore, precautions should be taken in the safe use of Fe2 O3 -NPs to avoid complications in the fertility of males. Further research will unravel the possible molecular mechanisms on testicular toxicity of Fe2 O3 -NPs. © 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 594-608, 2017.


Assuntos
Poluentes Ambientais/toxicidade , Compostos Férricos/toxicidade , Nanopartículas Metálicas/toxicidade , Testículo/efeitos dos fármacos , Animais , Apoptose , Ácido Ascórbico/metabolismo , Caspase 3/metabolismo , Catalase/metabolismo , Compostos Férricos/metabolismo , Glutationa/metabolismo , Peroxidação de Lipídeos , Masculino , Camundongos , Estresse Oxidativo , Carbonilação Proteica , Espécies Reativas de Oxigênio/metabolismo , Contagem de Espermatozoides , Espermatozoides/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Testículo/metabolismo , Testículo/patologia , Testosterona/sangue
2.
Chem Biol Interact ; 300: 91-100, 2019 Feb 25.
Artigo em Inglês | MEDLINE | ID: mdl-30639267

RESUMO

Ovarian cancer is the leading cause of gynaecology related cancer death worldwide. It is often diagnosed with an advanced stage. Apoptosis is a process of programmed cell death controlled by cell cycle machinery and several signaling pathways. Plant-derived compounds have received an increased interest in the treatment of cancer. Quercetin is a flavonoid present in fruits and vegetables which possess anticancer properties. Several studies have been demonstrated that quercetin induces apoptosis in various cancers. However, the apoptotic role of quercetin in metastatic ovarian cancer has not been extensively studied. In the present study, we investigated the apoptotic effect of quercetin on human metastatic ovarian cancer PA-1 cell line. Quercetin treatment (0-200 µM) for 24h decreases PA-1 cells viability in a dose-dependent manner. The effective dose was identified as 50 and 75 µM based on MTT assay. Quercetin induces apoptosis in metastatic ovarian cancer cells which were confirmed by AO/EtBr dual staining, DAPI staining and DNA fragmentation assay. Molecules involved in the intrinsic apoptotic pathway were altered by quercetin. Interestingly, antiapoptotic molecules such as Bcl-2, Bcl-xL were decreased while proapoptotic molecules such as caspase-3, caspase-9, Bid, Bad, Bax and cytochrome c were increased in the quercetin-treated PA-1 cells. Our results indicate that quercetin induces mitochondrial-mediated apoptotic pathway and thus it inhibits the growth of metastatic ovarian cancer cells.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Apoptose/efeitos dos fármacos , Quercetina/farmacologia , Caspase 3/metabolismo , Caspase 9/metabolismo , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Citocromos c/metabolismo , Fragmentação do DNA/efeitos dos fármacos , Feminino , Humanos , Metástase Neoplásica , Neoplasias Ovarianas/metabolismo , Neoplasias Ovarianas/patologia , Proteínas Proto-Oncogênicas c-bcl-2/genética , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína X Associada a bcl-2/genética , Proteína X Associada a bcl-2/metabolismo
3.
Int J Biochem Cell Biol ; 90: 38-47, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28739533

RESUMO

Environmental estrogens bind to estrogen receptors, mimic estrogenic actions, and have adverse effects on human health like Bisphenol - A (BPA) which is used as a monomer in the production of polycarbonate plastics (PC) and epoxy resins which are used in variety of canned foods. Skeletal muscle plays an essential role in maintaining systemic glucose metabolism. In the present study, we investigated the possible effects of BPA on insulin signalling molecules and GLUT4 translocation in the gastrocnemius muscle of adult male rat. Rats were divided into four groups - Group I: Control (vehicle-corn oil treated), Group II, III and IV were administered with BPA (10, 100 and 400mg/kg b.wt/day, respectively) through oral gavage. Fasting blood glucose level of BPA treated groups showed a significant increase, oral glucose tolerance and insulin tolerance were also impaired in these animals. BPA significantly decreased the protein levels of insulin signalling molecules like IR, IRS-1, Akt, AS160 and its phosphorylated forms and blunts GLUT4 translocation by altering the levels of v- and t- SNARE proteins that assist the translocation process, thereby decreasing glucose uptake and oxidation in the gastrocnemius muscle. These results suggest that BPA has detrimental effects on insulin signalling molecules and GLUT4 translocation in the gastrocnemius muscle and thus impairs glucose homeostasis.


Assuntos
Compostos Benzidrílicos/farmacologia , Disruptores Endócrinos/farmacologia , Transportador de Glucose Tipo 4/metabolismo , Insulina/metabolismo , Músculo Esquelético/citologia , Músculo Esquelético/efeitos dos fármacos , Fenóis/farmacologia , Transdução de Sinais/efeitos dos fármacos , Animais , Hormônios/sangue , Masculino , Músculo Esquelético/metabolismo , Transporte Proteico/efeitos dos fármacos , Ratos
4.
Toxicology ; 386: 60-71, 2017 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-28526321

RESUMO

Di-(2-ethyl hexyl) phthalate (DEHP) is the plasticizer used in variety of medical and consumer products to impart structural flexibility. DEHP and its primary metabolite mono-(2-ethyl hexyl)phthalate (MEHP) posed a considerable interest because of their contribution to insulin resistance, type-2 diabetes and obesity. Experimental and epidemiological data have shown that DEHP affects blood glucose homeostasis. However, direct effect of DEHP and its metabolite MEHP on insulin signal transduction and glucose transporter 4 (GLUT4) translocation remain obscure. The present study was delineated to decipher the direct effects of DEHP and MEHP on insulin signal transduction and proteins involved in GLUT4 translocation in cultured L6 myotubes, the rat skeletal muscle model. For this study we have exposed cells with 50 and 100µM DEHP and MEHP for 24h followed by insulin stimulation for 20min. GLUT4 level in both cytosol and plasma membrane fractions were analysed by western blot analysis and found to be significantly decreased. Further, DEHP and MEHP treatment significantly altered the insulin signalling molecules and proteins involved in GLUT4 translocation (Rab8A (Ras related proteins in skeletal muscle), insulin - regulated amino peptidase (IRAP), synaptosomal - associated protein 23 (SNAP23), Syntaxin4, Munc18c) from cytosol to plasma membrane. Impaired GLUT4 in the plasma membrane resulted in decreased 14C-deoxy glucose uptake. 14C-glucose oxidation and glycogen content were also significantly decreased in treated groups. In essence, the present study is first of its kind to show the direct adverse effects of DEHP and MEHP on insulin signal transduction and GLUT4 translocation in cultured L6 myotubes. Further, MEHP is found to be more effective than DEHP as a result of its differential structure and physico-chemical properties.


Assuntos
Dietilexilftalato/análogos & derivados , Transportador de Glucose Tipo 4/metabolismo , Insulina/metabolismo , Fibras Musculares Esqueléticas/efeitos dos fármacos , Plastificantes/toxicidade , Animais , Glicemia/efeitos dos fármacos , Membrana Celular/metabolismo , Células Cultivadas , Desoxiglucose/metabolismo , Dietilexilftalato/administração & dosagem , Dietilexilftalato/toxicidade , Relação Dose-Resposta a Droga , Glicogênio/metabolismo , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/efeitos dos fármacos , Plastificantes/administração & dosagem , Ratos , Transdução de Sinais/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA